By Helgi Library - August 11, 2020
Apotea made a net profit of SEK 24.4 mil with revenues of SEK 2,092 mil in 2018, down by 24.4% and up by 36.3%, res...
By Helgi Library - August 11, 2020
Apotea made a net profit of SEK 24.4 mil with revenues of SEK 2,092 mil in 2018, down by 24.4% and up by 36.3%, res...
By Helgi Library - August 11, 2020
Apotea made a net profit of SEK 24.4 mil with revenues of SEK 2,092 mil in 2018, down by 24.4% and up by 36.3%, respectively...
| Profit Statement | 2016 | 2017 | 2018 | |
| Sales | SEK mil | 983 | 1,535 | 2,092 |
| EBITDA | SEK mil | 15.8 | 57.0 | 46.1 |
| EBIT | SEK mil | 14.3 | 41.6 | 31.6 |
| Financing Cost | SEK mil | 0.088 | 0.018 | 0.010 |
| Net Profit | SEK mil | 11.2 | 32.2 | 24.4 |
| Balance Sheet | 2016 | 2017 | 2018 | |
| Total Assets | SEK mil | 150 | 238 | 332 |
| Non-Current Assets | SEK mil | 3.71 | 18.8 | 48.9 |
| Current Assets | SEK mil | 146 | 220 | 283 |
| Shareholders' Equity | SEK mil | 44.5 | 66.2 | 70.8 |
| Liabilities | SEK mil | 105 | 172 | 261 |
| Ratios | 2016 | 2017 | 2018 | |
| ROE | % | 28.7 | 58.2 | 35.6 |
| EBITDA Margin | % | 1.60 | 3.72 | 2.20 |
| EBIT Margin | % | 1.46 | 2.71 | 1.51 |
| Net Margin | % | 1.14 | 2.10 | 1.16 |
| Cash Flow | 2016 | 2017 | 2018 | |
| Cash Earnings | SEK mil | 12.6 | 47.6 | 38.8 |
Get all company financials in excel:
| overview | Unit | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
| income statement | |||||||||
| Sales | SEK mil | 35.1 | 108 | 288 | 586 | 983 | |||
| EBIT | SEK mil | -1.53 | 4.22 | 5.14 | 10.7 | 14.3 | |||
| Net Profit | SEK mil | -1.54 | 4.20 | 5.05 | 10.6 | 11.2 | |||
| ROE | % | ... | -39.0 | 35.7 | 24.8 | 37.8 | 28.7 | ||
| EBIT Margin | % | -4.35 | 3.92 | 1.78 | 1.83 | 1.46 | |||
| Net Margin | % | -4.37 | 3.90 | 1.75 | 1.82 | 1.14 | |||
| Employees | ... | ... | 20.0 | ... | ... | ... | ... | ... | |
| balance sheet | |||||||||
| Total Assets | SEK mil | 11.8 | 32.7 | 56.3 | 101 | 150 | |||
| Non-Current Assets | SEK mil | 2.06 | 2.19 | 4.70 | 4.21 | 3.71 | |||
| Current Assets | SEK mil | 9.70 | 30.5 | 51.6 | 96.5 | 146 | |||
| Shareholders' Equity | SEK mil | 5.67 | 17.9 | 22.9 | 33.4 | 44.5 | |||
| Liabilities | SEK mil | 6.08 | 14.8 | 33.4 | 67.3 | 105 | |||
| Current Liabilities | SEK mil | 6.08 | 14.8 | 33.4 | 67.3 | 105 |
| income statement | Unit | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
| income statement | |||||||||
| Sales | SEK mil | 35.1 | 108 | 288 | 586 | 983 | |||
| EBITDA | SEK mil | -0.968 | 4.86 | 5.87 | 12.1 | 15.8 | |||
| Depreciation | SEK mil | 0.561 | 0.646 | 0.726 | 1.40 | 1.44 | |||
| EBIT | SEK mil | -1.53 | 4.22 | 5.14 | 10.7 | 14.3 | |||
| Financing Cost | SEK mil | 0.008 | 0.019 | 0.091 | 0.066 | 0.088 | |||
| Tax | SEK mil | ... | ... | ... | ... | ... | 3.08 | ||
| Net Profit | SEK mil | -1.54 | 4.20 | 5.05 | 10.6 | 11.2 | |||
| Net Profit Avail. to Common | SEK mil | -1.54 | 4.20 | 5.05 | 10.6 | 11.2 | |||
| growth rates | |||||||||
| Total Revenue Growth | % | ... | 189 | 206 | 168 | 103 | 67.9 | ||
| Operating Cost Growth | % | ... | 13.9 | 185 | 174 | 103 | 68.7 | ||
| EBITDA Growth | % | ... | -95.0 | -602 | 20.6 | 106 | 30.3 | ||
| EBIT Growth | % | ... | -92.2 | -376 | 21.9 | 108 | 33.9 | ||
| Net Profit Growth | % | ... | -92.2 | -373 | 20.3 | 111 | 4.99 | ||
| ratios | |||||||||
| ROE | % | ... | -39.0 | 35.7 | 24.8 | 37.8 | 28.7 | ||
| ROA | % | ... | -17.2 | 18.9 | 11.3 | 13.6 | 8.92 | ||
| EBITDA Margin | % | -2.75 | 4.52 | 2.04 | 2.07 | 1.60 | |||
| EBIT Margin | % | -4.35 | 3.92 | 1.78 | 1.83 | 1.46 | |||
| Net Margin | % | -4.37 | 3.90 | 1.75 | 1.82 | 1.14 |
| balance sheet | Unit | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
| balance sheet | |||||||||
| Receivables | SEK mil | 0.412 | 4.75 | 9.44 | 8.98 | 15.7 | |||
| Current Assets | SEK mil | 9.70 | 30.5 | 51.6 | 96.5 | 146 | |||
| Non-Current Assets | SEK mil | 2.06 | 2.19 | 4.70 | 4.21 | 3.71 | |||
| Total Assets | SEK mil | 11.8 | 32.7 | 56.3 | 101 | 150 | |||
| Trade Payables | SEK mil | 5.39 | 12.8 | 30.2 | 60.5 | 93.9 | |||
| Other ST Liabilities | SEK mil | 0.696 | 1.99 | 3.26 | 6.85 | 11.2 | |||
| Current Liabilities | SEK mil | 6.08 | 14.8 | 33.4 | 67.3 | 105 | |||
| Other LT Liabilities | SEK mil | ... | 0.001 | ... | ... | ... | 0.001 | ||
| Liabilities | SEK mil | 6.08 | 14.8 | 33.4 | 67.3 | 105 | |||
| Share Capital | SEK mil | 0.659 | 0.659 | 0.659 | 0.694 | 0.694 | |||
| Equity Before Minority Interest | SEK mil | 5.67 | 17.9 | 22.9 | 33.4 | 44.5 | |||
| Equity | SEK mil | 5.67 | 17.9 | 22.9 | 33.4 | 44.5 | |||
| growth rates | |||||||||
| Total Asset Growth | % | ... | 92.1 | 178 | 72.3 | 78.7 | 48.6 | ||
| Shareholders' Equity Growth | % | ... | 157 | 215 | 28.3 | 45.6 | 33.5 | ||
| ratios | |||||||||
| Current Ratio | 1.59 | 2.06 | 1.55 | 1.43 | 1.39 |
| cash flow | Unit | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
| cash flow | |||||||||
| Net Profit | SEK mil | -1.54 | 4.20 | 5.05 | 10.6 | 11.2 | |||
| Depreciation | SEK mil | 0.561 | 0.646 | 0.726 | 1.40 | 1.44 | |||
| ratios | |||||||||
| Days Sales Outstanding | days | 4.28 | 16.1 | 12.0 | 5.60 | 5.81 | |||
| Cash Earnings | SEK mil | -0.976 | 4.85 | 5.78 | 12.0 | 12.6 |
| other ratios | Unit | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
| Employees | ... | ... | 20.0 | ... | ... | ... | ... | ... | |
| Operating Cost (As % of Sales) | % | 103 | 95.5 | 98.0 | 97.9 | 98.4 | |||
| Total Revenue Growth (5-year average) | % | ... | ... | ... | ... | ... | 141 |
Get all company financials in excel:
By Helgi Library - August 11, 2020
Apotea made a net profit of SEK 24.4 mil with revenues of SEK 2,092 mil in 2018, down by 24.4% and up by 36.3%, respectively, compared to the previous year. This translates into a net margin of 1.16%. Historically, between 2011 and 2018, the firm’...
Apotea AB is a Sweden-based operator of an online full-scale pharmacy store. The company's online pharmacy store offers a full range of both prescription and non-prescription drugs for allergy, face, animal, fever and pain, cold, skin and hair, hands and feet, stomach and intestine, mouth and teeth, wound, vitamins and minerals and for various other diseases, enabling customers to meet their pharmaceutical requirements conveniently. The Company was founded in 2003.
Apotea has been growing its sales by 81.0% a year on average in the last 5 years. EBITDA has grown on average by 56.8% a year during that time to total of SEK 46.1 mil in 2018, or 2.20% of sales. That’s compared to 2.33% average margin seen in last five years.
The company netted SEK 24.4 mil in 2018 implying ROE of 35.6% and ROCE of . Again, the average figures were 37.0% and %, respectively when looking at the previous 5 years.
Apotea’s net debt amounted to at the end of 2018, or of equity. When compared to EBITDA, net debt was x, up when compared to average of x seen in the last 5 years.
Helgi Library 
